| Eradication of large established tumors in mice by combination immunotherapy that engages innate and adaptive immune responses KD Moynihan, CF Opel, GL Szeto, A Tzeng, EF Zhu, JM Engreitz, ... Nature medicine 22 (12), 1402-1410, 2016 | 524 | 2016 |
| Antigen specificity can be irrelevant to immunocytokine efficacy and biodistribution A Tzeng, BH Kwan, CF Opel, T Navaratna, KD Wittrup Proceedings of the National Academy of Sciences 112 (11), 3320-3325, 2015 | 124 | 2015 |
| Human breast microbiome correlates with prognostic features and immunological signatures in breast cancer A Tzeng, N Sangwan, M Jia, CC Liu, KS Keslar, E Downs-Kelly, ... Genome Medicine 13, 1-17, 2021 | 114 | 2021 |
| The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice ES Lamousé-Smith, A Tzeng, MN Starnbach PloS one 6 (11), e27662, 2011 | 114 | 2011 |
| Protein engineering and selection using yeast surface display A Angelini, TF Chen, S de Picciotto, NJ Yang, A Tzeng, MS Santos, ... Yeast Surface Display: Methods, Protocols, and Applications, 3-36, 2015 | 102 | 2015 |
| Treating periprosthetic joint infections as biofilms: key diagnosis and management strategies A Tzeng, TH Tzeng, S Vasdev, K Korth, T Healey, J Parvizi, KJ Saleh Diagnostic microbiology and infectious disease 81 (3), 192-200, 2015 | 89 | 2015 |
| Temporally programmed CD8α+ DC activation enhances combination cancer immunotherapy A Tzeng, MJ Kauke, EF Zhu, KD Moynihan, CF Opel, NJ Yang, N Mehta, ... Cell reports 17 (10), 2503-2511, 2016 | 54 | 2016 |
| Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses BH Kwan, EF Zhu, A Tzeng, HR Sugito, AA Eltahir, B Ma, MK Delaney, ... Journal of Experimental Medicine 214 (6), 1679-1690, 2017 | 51 | 2017 |
| Evaluation and management of metal hypersensitivity in total joint arthroplasty: a systematic review M Amini, WH Mayes, A Tzeng, TH Tzeng, KJ Saleh, WM Mihalko Journal of long-term effects of medical implants 24 (1), 2014 | 39 | 2014 |
| Immunological correlates of response to immune checkpoint inhibitors in metastatic urothelial carcinoma A Tzeng, CM Diaz-Montero, PA Rayman, JS Kim, PG Pavicic, JH Finke, ... Targeted Oncology 13, 599-609, 2018 | 26 | 2018 |
| The role of patient activation in achieving better outcomes and cost-effectiveness in patient care A Tzeng, TH Tzeng, S Vasdev, A Grindy, JK Saleh, KJ Saleh JBJS reviews 3 (1), e4, 2015 | 18 | 2015 |
| Order of administration of combination cytokine therapies can decouple toxicity from efficacy in syngeneic mouse tumor models A Rothschilds, A Tzeng, NK Mehta, KD Moynihan, DJ Irvine, KD Wittrup Oncoimmunology 8 (5), e1558678, 2019 | 15 | 2019 |
| Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis A Tzeng, TH Tzeng, MC Ornstein Journal for Immunotherapy of Cancer 9 (10), 2021 | 8 | 2021 |
| Interplay between class II HLA genotypes and the microbiome and immune phenotypes in individuals with PTEN hamartoma tumor syndrome M Jia, N Sangwan, A Tzeng, C Eng JCO precision oncology 5, 357-369, 2021 | 3 | 2021 |
| Fecal microbiota of adolescent and young adult cancer survivors and metabolic syndrome: An exploratory study SJ Rotz, N Sangwan, M Nagy, A Tzeng, M Jia, M Moncaliano, NS Majhail, ... Pediatric hematology and oncology 39 (7), 629-643, 2022 | 1 | 2022 |
| Serial changes in PD1/PDL1 expression in metastatic urothelial carcinoma (mUC) patients (pts) treated with immune checkpoint blockade (CPB). A Tzeng, CM Diaz-Montero, PA Rayman, JS Kim, PG Pavicic, J Finke, ... Journal of Clinical Oncology 36 (5_suppl), 109-109, 2018 | 1 | 2018 |
| Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof SM Cheal, H Xu, SM Larson, NK Cheung, KD Wittrup | 1 | 2017 |
| Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to … A Nizam, RK Rader, A Tzeng, W Wei, IYF Sheng, A Martin, CE Wee, ... Clinical Genitourinary Cancer 22 (2), 368-379, 2024 | | 2024 |
| Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study LI Banla, A Tzeng, JP Baillieul, MJ Kandekhar, KJ Fitzgerald, J LoPiccolo, ... JTO Clinical and Research Reports 4 (10), 100559, 2023 | | 2023 |
| Immunological correlates of response and immune-mediated toxicity in checkpoint inhibitor (ICI)-treated metastatic urothelial carcinoma (mUC) patients (pts). A Nizam, A Tzeng, W Wei, PA Rayman, PG Pavicic, V Makarov, I Juric, ... Journal of Clinical Oncology 40 (6_suppl), 526-526, 2022 | | 2022 |
Kelly D. MoynihanMITBestätigte E-Mail-Adresse bei mit.edu
